Opthea Limited has announced that its global Phase 3 clinical trial, known as COAST (Combination OPT...

ZEISS Medical Technology has announced the Canadian availability of its advanced VISULAS® Combi lase...

Alcon has announced a definitive merger agreement to acquire Lensar, Inc., marking a significant exp...

The Glaucoma Research Foundation has named nine researchers as recipients of its 2025 Shaffer Resear...

Kalaris Therapeutics and AlloVir Inc. have finalized their merger, forming a new entity under the Ka...

Formosa Pharmaceuticals has signed an exclusive licensing agreement with Cipla for the commercializa...

Ocugen has received clearance from its Data and Safety Monitoring Board (DSMB) to proceed with the s...

Bausch + Lomb has announced the U.S. launch of Arise, an advanced lens fitting system that leverages...

OSRX is expanding its pharmaceutical offerings with new medication sizes and direct-to-patient post-...

Nicox has announced the completion of data collection for the Whistler Phase 3b clinical trial inves...